ALN-2232

ALN-2232 · Alnylam Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALN-2232, covering 2026-03-11 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate ALN-2232 in Participants With Obesity [Phase 1, Phase 2]